Search

Author/Creator Gensch, Victoria

1. Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. Issue 3 (4th March 2019)

Authors:
Janning, Melanie; Müller, Volkmar; Vettorazzi, Eik; Cubas‐Cordova, Miguel; Gensch, Victoria; Ben‐Batalla, Isabel; zu Eulenburg, Christine; Schem, Christian; Fasching, Peter A.; Schnappauf, Benjamin; Karn, Thomas; Fehm, Tanja; Just, Marianne; Kühn, Thorsten; Holms, Frank; Overkamp, Friedrich; Krab...
Journal:
International journal of cancer
Issue:
Volume 145:Issue 3(2019)
Page Start:
857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms. Issue 9 (11th September 2021)

Authors:
Beitzen-Heineke, Antonia; Berenbrok, Nikolaus; Waizenegger, Jonas; Paesler, Sarina; Gensch, Victoria; Udonta, Florian; Vargas Delgado, Maria Elena; Engelmann, Janik; Hoffmann, Friederike; Schafhausen, Philippe; von Amsberg, Gunhild; Riecken, Kristoffer; Beumer, Niklas; Imbusch, Charles D.; Lorens...
Journal:
HemaSphere
Issue:
Volume 5:Issue 9(2021)
Page Start:
e630
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search